Abstract
Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels and include coronary heart disease (CHD), cerebrovascular disease, raised blood pressure (hypertension), rheumatic heart disease, angina, peripheral arterial disease, atherosclerosis, congenital heart disease, heart failure, and deep vein thrombosis (WHO 2009). Cardiovascular disease is the leading cause of death worldwide accounting for about 40 % of global mortality and 10.3 % of the global burden of disease. The incidence of CVD has risen greatly in low- and middle-income countries (Yusuf et al. 2001). Among cardiovascular disease, CHD is the most common heart disease, responsible for 40–60 % of all deaths and is invariably associated with atherosclerosis (thickening of the arteries). Atherosclerosis is a major cause of CVD that develops slowly over decades. In atherosclerosis, narrowing of the vessel’s lumen may lead to obstruction and to its clinical manifestations, such as myocardial infarction (MI) (Lefant and Savage 1995). Although women do not suffer from this problem as frequently as men, but it is numerically more significant in the case of older women. It has been reported that the risk of CHD is more in postmenopausal women (Miller 1990). Angina pectoris is one of the several expressions and one of possible manifestations of coronary heart disease. It is precipitated when the oxygen demands of the myocardium exceeds the available arterial oxygen supply. The major modifiable risk factors for CVD include high blood pressure (hypertension), high total cholesterol, obesity, physical inactivity, unhealthy diet, diabetes mellitus (DM), and homocysteine levels (Mackay and Mensah 2004). The more risk factors a person has, the greater the likelihood of developing CVD. Risk of CHD is two- to threefold higher in persons having type II diabetes as compared to general population (Fox et al. 2004). In diabetes, cardiovascular disease affects both men and women to the same extent (Uusitupa et al. 1993). It has been observed that women with diabetes, regardless of menopausal status, have a four- to sixfold higher risk of developing CVD, whereas men with diabetes have a two- to threefold increased risk of CVD compared to women and men without diabetes (Legato et al. 2006). Individuals having DM also face the risk of developing atherosclerosis due to the disturbances in the lipid metabolism (Adlerberth et al. 1998). Furthermore, high-density lipoprotein cholesterol (HDL cholesterol) that is commonly regarded as protective is decreased in diabetic patients. Diabetes mellitus acts as an independent risk factor for several forms of CVD, and it has been estimated that approximately 65 % of CVD-caused deaths are of the persons with DM (Geiss et al. 1995). Diabetes accounts for 6 % of total global mortality, with 50 % of diabetes-associated deaths being attributed to CVD (International Diabetes Federation 2008).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adlerberth AM, Rosengren A, Wilhelmsen L (1998) Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 21(4):539–545
Al-Delaimy WK, Rimm EB, Willett WC (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23:63–70
Aliabadi H (2008) A deleterious interaction between copper deficiency and sugar ingestion may be the missing link in heart disease. Med Hypotheses 70(6):1163–1166
Chausmer A (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109–115
Feroci G, Badiello R, Fini A (2005) Interactions between different selenium compounds and zinc, cadmium and mercury. J Trace Elem Med Biol 18:227–234
Fox CS, Sullivan L, D’Agostino RB Sr, Wilson PW (2004) The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 27(3):704–708
Geiss LS, Herman WH, Smith PJ, National Diabetes Data Group (1995) Diabetes in America. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, pp 233–257
Gonzalez S, Huerta JM, Alvarez-Uria J, Fernandez S, Patterson AM, Lasheras C (2004) Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr 134(7):1736–1740
Helmersson J, Arnlov J, Vessby B, Larsson A, Alfthan G, Basu S (2005) Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2α in a 27 year follow-up study of Swedish men. Free Radic Res 39:763–770
Howard BV, Lee ET, Yeh JL, Go O, Fabsitz RR, Devereux RB, Welty TK (1996) Hypertension in adult American Indians. Hypertension 28:256–264
International Diabetes Federation (2008) Diabetes prevalence [article online]. Available from http://www.idf.org/home/index.cfm?node=264
Jenner A, Ren B, Rajendran R, Ning P, Huat BTK, Watt F, Halliwell B (2007) Zinc supplementation inhibits lipid per oxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic Biol Med 42:559–566
Kh R, Khullar M, Kashyap M, Pandlu P, Uppal R (2000) Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats. J Hypertens 18:919–926
Lefant C, Savage PJ (1995) The early natural history of atherosclerosis and hypertension in the young: National Institutes of Health Perspectives. Am J Med Sci 310(Suppl 1):S3–S7
Legato MJ, Gelze RA, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M (2006) Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 3:131–158
Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S–811S
Linnebank M, Lutz H, Jarre E, Vielhaber S, Noelker C, Struys E (2006) Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells. Neurobiol Dis 23(3):725–730
Lissa EM, Bahjri SM, Ahmed WH, Al-Ama N, Ferns GA (2006) Trace element status in Saudi patients with established atherosclerosis. J Trace Elem Med Biol 20:105–114
Ma B, Lawson AB, Liese AD (2006) Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 164:449–458
Mackay J, Mensah G (2004) Atlas of heart disease and stroke. World Health Organization, Geneva
Mazur A, Maier JAM, Rock E (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458:48–56
Miller VT (1990) Dyslipoproteinemia in women. Special considerations. Endocrinol Metab Clin North Am 19(2):381–398
Mostert V (2000) Selenoprotein P: properties, functions and regulation. Arch Biochem Biophys 376:433–438
Navarro-Alarcon M, López-Martínez MC (2000) Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ 249:347–371
Nayak D, Karmen C, Frishman W, Vakili B (2001) Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis 3(1):28–45
Powell S (2000) The antioxidant properties of zinc. J Nutr 130:1447S–1454S
Rajpathak S, Rimm E, Morris JS, Hu F (2005) Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 24:250–256
Ravn-Haren G, Bugel S, Krath BN, Hoac T, Stagsted J, Jorgensen K, Bresson JR, Larsen EH, Dragsted LO (2008) A short-term intervention trial with selenate, selenium-enriched yeast and selenium enriched milk: effects on oxidative defense regulation. Br J Nutr 99:883–892
Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241
Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson R (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316–321
Shaper G, Kazantzis G, Schoental R (1979) Cardiovascular disease and trace metals. Proc R Soc Lond B 205:135–143
Shekelle RB, Shryock AM, Oblesby P (1981) Diet, serum cholesterol, and death from coronary heart disease: the Western Electric Study. N Engl J Med 304:65–70
Speich M, Pineau A, Ballereau F (2001) Minerals, trace elements and related biological variables in athletes and during physical activity. Clin Chim Acta 312(1–2):1–11
Suarez A, Pulido N, Casla A (1995) Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemia rats. Diabetologia 38:1262–1270
Teragawa H, Kato M, Yamagat T, Matsuura H, Kajiyama G (2000) The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 118:1690–1695
Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184
Vitale J (1992) Magnesium deficiency and cardiovascular disease. Lancet 340:1224
Vlad M, Berdas E, Tomas R, Sava D, Frakas E, Usa G (1993) Effect of copper sulfate in experimental atherosclerosis. Biol Trace Elem Res 38:47–54
Waśkiewicz A, Piotrowski W, Sygnowska E, Broda G, Drygas W, Zdrojewski T, Kozakiewicz K, Tykarski A, Biela U (2008) Quality of nutrition and health knowledge in subjects with diagnosed cardiovascular diseases in the Polish population – National Multi-centre Health Survey (WOBASZ). Kardiol Pol 66:507–513
Wenger NK (2003) Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 46:199–229
Whelton PK (1994) Epidemiology of hypertension. Lancet 334:101–106
World Health Organization (WHO) (2009) Fact sheet about cardiovascular disease
Yusuf S, Reddy S, Ôunpuu S, Anand S (2001) Global burden of cardiovascular diseases, part I: general considerations, the epidemiological transition, risk factors, and impact of urbanization. Circulation 104:2746–2753
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rizvi, N.B., Nagra, S.A. (2014). Introduction: Minerals. In: Minerals and Lipids Profiles in Cardiovascular Disorders in South Asia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34249-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-34249-3_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-34248-6
Online ISBN: 978-3-642-34249-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)